Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)

2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) is listed in the pharmaceutical impurity collection under CAS 52806-53-8. Its represented structure has formula C11H11F3N2O4 and a calculated molecular weight of 292.21 g/mol.

2D chemical structure

H O O H N N + O O - F F F

Chemical identity

Catalog name
2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)
Common name
Not available
Chemical name
2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
CAS
52806-53-8
SMILES
CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1
InChI
InChI=1S/C11H11F3N2O4/c1-10(2,18)9(17)15-6-3-4-8(16(19)20)7(5-6)11(12,13)14/h3-5,18H,1-2H3,(H,15,17)
InChIKey
YPQLFJODEKMJEF-UHFFFAOYSA-N
Associated API
Flutamide

Record ID: A20d6b8357732

Computed properties

C11H11F3N2O4 Molecular formula
292.213 g/molMolecular weight
292.0671 DaMonoisotopic exact mass
92.47 ŲTopological polar surface area
2.323 Calculated LogP (Wildman–Crippen)
63.0259 cm³/molMolar refractivity (Wildman–Crippen)
4 countHydrogen-bond acceptors
2 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C F H N O 0 3 6 9 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight292.21341.85
Calculated LogP (Wildman–Crippen)2.32348.73
Topological polar surface area92.4767.24
Hydrogen-bond acceptors450.68
Hydrogen-bond donors264.87
Rotatable bonds (strict)337.08

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC11H11F3N2O4dimensionless
Molecular weight292.213g/mol
Monoisotopic exact mass292.0671Da
Topological polar surface area92.47Ų
Calculated LogP (Wildman–Crippen)2.323dimensionless
Molar refractivity (Wildman–Crippen)63.0259cm³/mol
Hydrogen-bond acceptors4count
Hydrogen-bond donors2count
Rotatable bonds (strict)3count
Heavy atoms20count
Heteroatoms9count
Rings1count
Aromatic rings1count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles0count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.3636fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area110.9113Ų
Valence electrons110count
Radical electrons0count
Bertz complexity549.5797index
Balaban J3.2086index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)

Qualification and safety assessment of 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)

Explore toxicological qualification of 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) and ICH M7 mutagenic impurity assessment of 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide) and acceptable intake and limit justification for 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide). The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 2-Hydroxy-2-methyl-N-[4-nitro-3- (trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)

Explore Altox services and software through the Altox Pharma-Hub.